https://a-485inhibitor.com/exe....rcising-retrieval-fa
Nomograms being established to anticipate survival in postoperative or senior intrahepatic cholangiocarcinoma (ICC) clients. There are no models to predict postoperative success in senior ICC patients. Extreme gradient boosting (XGBoost) can adjust the errors produced by existing designs. This retrospective cohort study aimed to develop and validate an XGBoost design to predict postoperative 5-year survival in senior ICC clients. The Surveillance, Epidemiology, and End Results (SEER) program provided information on e
Like
Comment
Share
